|The CYTOMEGALOVIRUS EARLY NUCLEAR ANTIGEN n/a (Catalog #MBS216748) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CYTOMEGALOVIRUS EARLY NUCLEAR ANTIGEN can be used in a range of immunoassay formats including, but not limited to, Immunohistology Frozen, ELISA (EIA), Immunofluorescence (IF), Immunohistology Paraffin.
Immunohistology: Suitable for methacam fixed, paraffin wax embedded sections as well as acetone fixed CMV infected cells or frozen sections. Researchers should empirically determine the suitability of the CYTOMEGALOVIRUS EARLY NUCLEAR ANTIGEN n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse anti Cytomegalovirus Early Nuclear Antigen antibody, clone HCMV3 detects cytomegalovirus early nuclear antigen. Cytomegalovirus is an enveloped double stranded DNA virus which in humans (HCMV) is also commonly known as human herpesvirus 5 (HHV-5). Early HCMV proteins are expressed in the nucleus of infected cells within 3 to 24 hours of infection, prior to viral DNA replication. Mouse anti Cytomegalovirus Early Nuclear Antigen antibody, clone HCMV3 is also reactive with MRC-5 cells infected with CMV, but not uninfected cells.
Perservative Stabilisers: 0.09% Sodium Azide (NaN3)
Preparation: Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant. Immunogen: Human CMV extracts
Buffer Solution: Phosphate buffered saline
Target Species: Viral. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CYTOMEGALOVIRUS EARLY NUCLEAR ANTIGEN are readily searchable from our website. Different antibodies against the same target such as CYTOMEGALOVIRUS EARLY NUCLEAR ANTIGEN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.